Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Capital Employed (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Return on Capital Employed for 15 consecutive years, with 1.89% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 181.0% to 1.89% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.89%, a 181.0% decrease, with the full-year FY2024 number at 0.03%, down 3.0% from a year prior.
  • Return on Capital Employed was 1.89% for Q3 2025 at Harvard Bioscience, up from 1.96% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.05% in Q1 2023 to a low of 1.96% in Q2 2025.
  • A 5-year average of 0.27% and a median of 0.02% in 2022 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: increased 11bps in 2023, then tumbled -190bps in 2025.
  • Harvard Bioscience's Return on Capital Employed stood at 0.0% in 2021, then crashed by -7077bps to 0.02% in 2022, then surged by 69bps to 0.0% in 2023, then tumbled by -591bps to 0.03% in 2024, then plummeted by -5599bps to 1.89% in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Return on Capital Employed are 1.89% (Q3 2025), 1.96% (Q2 2025), and 1.05% (Q1 2025).